Windlas Biotech added 1.76% to Rs 1,033.15 after the company announced that its new state-of-the-art injectable facility has received Good Manufacturing Practices (GMP) certification.

Windlas Biotech Limited, a leading Indian pharmaceutical CDMO, announced today that its new injectable manufacturing facility has received Good Manufacturing Practices (GMP) certification from ...

New Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central ...

Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority ...

Windlas Biotech Ltd share price was up by 0.31% from the previous closing price of ₹1,004.15. Who are peers of Windlas Biotech Ltd? The peers of Windlas Biotech Ltd are Sun Pharmaceuticals ...

Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name ...

Windlas Biotech Limited is an India-base domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The Company provides a comprehensive range of CDMO ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Get daily newsletters around different themes from livemint.

Burmans' Religare Open Offer to Acquire 26% Stake Starts Jan 27 Burmans' Religare Enterprises' open offer to acquire an additional 26% stake in Religare Enterprises Ltd (REL) will commence on January ...

At close: January 10 at 3:29:54 PM GMT+5:30 ...